Tech Company Financing Transactions
Pattern Bioscience Funding Round
Pattern Bioscience, based in Austin, received $9 million in investment from Illumina Ventures and Omnimed Capital.
Transaction Overview
Company Name
Announced On
7/15/2020
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Series B
Investors
Illumina Ventures (Lead Investor) (Nick Naclerio)
Proceeds Purpose
The company intends to use the funds to accelerate development and validation of its transformational bacterial testing technology.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
9600 Great Hills Trail 160E
Austin, TX 78759
USA
Austin, TX 78759
USA
Phone
Undisclosed
Website
Email Address
Overview
Our mission is simple: We will improve the world's most important health decisions. Whether you call them superbugs, pan-resistant organisms, or just plain deadly, drug-resistant microbes have become a global public health crisis. Pattern is a clinical diagnostics company dedicated to bringing experience, innovation and technology to the fight against antibiotic resistance.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nick Arab
VP - Bus. Development
Kyle Fieleke
VP - Engineering
Ross Johnson
VP - Human Resources
Cindy Lopez
VP - R & D
David Bussian
Browse more venture capital transactions:
Prev: 7/15/2020: Medly Pharmacy venture capital transaction
Next: 7/15/2020: GuidePoint Security venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs